NCT07506798 Impact of Combined Intravenous-Inhalational vs Inhalational Anesthesia on QoR-15 Recovery Scores in Gynecologic Surgery
| NCT ID | NCT07506798 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sakarya University |
| Condition | Gynecologic Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-10-01 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effects of combined intravenous-inhalational anesthesia versus inhalational anesthesia alone on postoperative recovery in patients undergoing elective gynecologic surgery. A total of 100 patients, aged 18-65 years and classified as ASA I-III, scheduled for elective gynecologic procedures at Sakarya University Faculty of Medicine Training and Research Hospital, will be included. The sample size was calculated based on the primary outcome, the Quality of Recovery-15 (QoR-15) score. Patients will complete the QoR-15 questionnaire preoperatively, before knowing which anesthesia method will be applied. Postoperative QoR-15 scores will be collected on postoperative days 1 and 2, and intraoperative data will be obtained from anesthesia records. The study evaluates postoperative recovery using QoR-15 scores, covering physical comfort, emotional state, psychological support, pain, and ability to perform daily activities. Higher scores indicate better recovery, whereas lower scores indicate impaired postoperative recovery.
Eligibility Criteria
Inclusion Criteria: 1. Patients aged 18-65 years 2. Scheduled for elective gynecologic surgery at Sakarya University Faculty of Medicine Training and Research Hospital 3. Classified as ASA I-III 4. Able to understand and complete the QoR-15 questionnaire 5. Provided written informed consent Exclusion Criteria: 1. Severe comorbidities (beyond ASA III) 2. Patients with advanced neurological disease or cognitive impairment 3. Known allergy to anesthetic drugs used in the study 4. Classified as ASA IV-V 5. Refusal to participate in the study 6. Emergency or urgent surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07506798 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Gynecologic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07506798 currently recruiting?
Yes, NCT07506798 is actively recruiting participants. Contact the research team at Melikekar2015@gmail.com for enrollment information.
Where is the NCT07506798 trial being conducted?
This trial is being conducted at Sakarya, Turkey (Türkiye).
Who is sponsoring the NCT07506798 clinical trial?
NCT07506798 is sponsored by Sakarya University. The trial plans to enroll 100 participants.